Breast Cancer Diagnostics Market
Breast Cancer Diagnostics Market - Global Industry Assessment & Forecast
#
Pages:
250
Base Year:
2023
Jun - 2024
Format:
Report Code:
VMR-2523
Segments Covered
By
Type Imaging, Biopsy, Genomic Tests, Blood Tests, Others
-
By
Product Platform-based Products, Instrument-based Products
-
By
Application Screening, Diagnostic and Predictive, Prognostic, Research
-
By
End-use Hospitals & Clinics, Diagnostic Centers and Medical Laboratories, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 4.47 Billion |
 Revenue 2032:
|
USD 8.27 Billion |
 Revenue CAGR
(2024 - 2032): |
7.09% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Breast Cancer Diagnostics Market Segment Analysis
- Breast Cancer Diagnostics Type Outlook (Revenue, USD Million, 2018 - 2030)
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Breast Cancer Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)
- Platform-based Products
- Instrument-based Products
- Breast Cancer Diagnostics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Breast Cancer Diagnostics End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
-
North America Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
-
North America Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
-
North America Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- U.S.
- U.S. Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- U.S. Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- U.S. Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- U.S. Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- U.S. Breast Cancer Diagnostics Market, by Type
- Canada
- Canada Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Canada Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Canada Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Canada Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Canada Breast Cancer Diagnostics Market, by Type
-
Mexico
- Mexico Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Mexico Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Mexico Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Mexico Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Mexico Breast Cancer Diagnostics Market, by Type
-
North America Breast Cancer Diagnostics Market, by Type
- Europe
-
Europe Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
-
Europe Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
-
Europe Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
-
Europe Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- U. K.
- U.K. Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- U.K. Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- U.K. Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- U.K. Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- U.K. Breast Cancer Diagnostics Market, by Type
- France
- France Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- France Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- France Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- France Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- France Breast Cancer Diagnostics Market, by Type
-
Germany
- Germany Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Germany Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Germany Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Germany Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Germany Breast Cancer Diagnostics Market, by Type
-
Italy
- Italy Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Italy Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Italy Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Italy Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Italy Breast Cancer Diagnostics Market, by Type
-
Spain
- Spain Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Spain Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Spain Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Spain Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Spain Breast Cancer Diagnostics Market, by Type
-
Rest of Europe
- Rest of Europe Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Rest of Europe Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Rest of Europe Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Rest of Europe Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Rest of Europe Breast Cancer Diagnostics Market, by Type
-
Europe Breast Cancer Diagnostics Market, by Type
- Asia Pacific
-
Asia Pacific Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
-
Asia Pacific Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
-
Asia Pacific Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
-
Asia Pacific Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- China
- China Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- China Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- China Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- China Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- China Breast Cancer Diagnostics Market, by Type
- Japan
- Japan Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Japan Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Japan Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Japan Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Japan Breast Cancer Diagnostics Market, by Type
-
Germany
- Germany Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Germany Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Germany Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Germany Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Germany Breast Cancer Diagnostics Market, by Type
-
India
- India Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- India Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- India Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- India Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- India Breast Cancer Diagnostics Market, by Type
-
South Korea
- South Korea Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- South Korea Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- South Korea Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- South Korea Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- South Korea Breast Cancer Diagnostics Market, by Type
-
South East Asia
- South East Asia Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- South East Asia Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- South East Asia Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- South East Asia Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- South East Asia Breast Cancer Diagnostics Market, by Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Rest of Asia Pacific Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Rest of Asia Pacific Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Rest of Asia Pacific Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Rest of Asia Pacific Breast Cancer Diagnostics Market, by Type
-
Asia Pacific Breast Cancer Diagnostics Market, by Type
- Latin America
-
Latin America Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
-
Latin America Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
-
Latin America Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
-
Latin America Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Brazil
- Brazil Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Brazil Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Brazil Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Brazil Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Brazil Breast Cancer Diagnostics Market, by Type
- Argentina
- Argentina Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Argentina Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Argentina Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Argentina Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Argentina Breast Cancer Diagnostics Market, by Type
-
Rest of Latin America
- Rest of Latin America Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Rest of Latin America Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Rest of Latin America Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Rest of Latin America Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Rest of Latin America Breast Cancer Diagnostics Market, by Type
-
Latin America Breast Cancer Diagnostics Market, by Type
- Middle East & Africa
-
Middle East & Africa Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
-
Middle East & Africa Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
-
Middle East & Africa Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
-
Middle East & Africa Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- GCC Countries
- GCC Countries Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- GCC Countries Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- GCC Countries Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- GCC Countries Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- GCC Countries Breast Cancer Diagnostics Market, by Type
- South Africa
- South Africa Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- South Africa Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- South Africa Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- South Africa Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- South Africa Breast Cancer Diagnostics Market, by Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Breast Cancer Diagnostics Market, by Type
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
- Rest of Middle East & Africa Breast Cancer Diagnostics Market, by Product
- Platform-based Products
- Instrument-based Products
- Rest of Middle East & Africa Breast Cancer Diagnostics Market, by Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
- Rest of Middle East & Africa Breast Cancer Diagnostics Market, by End-use
- Hospitals & Clinics
- Diagnostic Centers and Medical Laboratories
- Others
- Rest of Middle East & Africa Breast Cancer Diagnostics Market, by Type
-
Middle East & Africa Breast Cancer Diagnostics Market, by Type
- North America
FAQ
Frequently Asked Question
What is the global demand for Breast Cancer Diagnostics in terms of revenue?
-
The global Breast Cancer Diagnostics valued at USD 4.47 Billion in 2023 and is expected to reach USD 8.27 Billion in 2032 growing at a CAGR of 7.09%.
Which are the prominent players in the market?
-
The prominent players in the market are BD, Koninklijke Philips N.V., Thermo Fisher Scientific Inc., Genomic Health (Exact Sciences Corporation), QIAGEN, Danaher, Hologic Inc., Myriad Genetics Inc., F. Hoffmann-La Roche Ltd., Argon Medical Devices.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 7.09% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Breast Cancer Diagnostics include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Breast Cancer Diagnostics in 2023.
